Cargando…

A Systems Level, Functional Genomics Analysis of Chronic Epilepsy

Neither the molecular basis of the pathologic tendency of neuronal circuits to generate spontaneous seizures (epileptogenicity) nor anti-epileptogenic mechanisms that maintain a seizure-free state are well understood. Here, we performed transcriptomic analysis in the intrahippocampal kainate model o...

Descripción completa

Detalles Bibliográficos
Autores principales: Winden, Kellen D., Karsten, Stanislav L., Bragin, Anatol, Kudo, Lili C., Gehman, Lauren, Ruidera, Josephine, Geschwind, Daniel H., Engel, Jerome
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3114768/
https://www.ncbi.nlm.nih.gov/pubmed/21695113
http://dx.doi.org/10.1371/journal.pone.0020763
_version_ 1782206108947972096
author Winden, Kellen D.
Karsten, Stanislav L.
Bragin, Anatol
Kudo, Lili C.
Gehman, Lauren
Ruidera, Josephine
Geschwind, Daniel H.
Engel, Jerome
author_facet Winden, Kellen D.
Karsten, Stanislav L.
Bragin, Anatol
Kudo, Lili C.
Gehman, Lauren
Ruidera, Josephine
Geschwind, Daniel H.
Engel, Jerome
author_sort Winden, Kellen D.
collection PubMed
description Neither the molecular basis of the pathologic tendency of neuronal circuits to generate spontaneous seizures (epileptogenicity) nor anti-epileptogenic mechanisms that maintain a seizure-free state are well understood. Here, we performed transcriptomic analysis in the intrahippocampal kainate model of temporal lobe epilepsy in rats using both Agilent and Codelink microarray platforms to characterize the epileptic processes. The experimental design allowed subtraction of the confounding effects of the lesion, identification of expression changes associated with epileptogenicity, and genes upregulated by seizures with potential homeostatic anti-epileptogenic effects. Using differential expression analysis, we identified several hundred expression changes in chronic epilepsy, including candidate genes associated with epileptogenicity such as Bdnf and Kcnj13. To analyze these data from a systems perspective, we applied weighted gene co-expression network analysis (WGCNA) to identify groups of co-expressed genes (modules) and their central (hub) genes. One such module contained genes upregulated in the epileptogenic region, including multiple epileptogenicity candidate genes, and was found to be involved the protection of glial cells against oxidative stress, implicating glial oxidative stress in epileptogenicity. Another distinct module corresponded to the effects of chronic seizures and represented changes in neuronal synaptic vesicle trafficking. We found that the network structure and connectivity of one hub gene, Sv2a, showed significant changes between normal and epileptogenic tissue, becoming more highly connected in epileptic brain. Since Sv2a is a target of the antiepileptic levetiracetam, this module may be important in controlling seizure activity. Bioinformatic analysis of this module also revealed a potential mechanism for the observed transcriptional changes via generation of longer alternatively polyadenlyated transcripts through the upregulation of the RNA binding protein HuD. In summary, combining conventional statistical methods and network analysis allowed us to interpret the differentially regulated genes from a systems perspective, yielding new insight into several biological pathways underlying homeostatic anti-epileptogenic effects and epileptogenicity.
format Online
Article
Text
id pubmed-3114768
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-31147682011-06-21 A Systems Level, Functional Genomics Analysis of Chronic Epilepsy Winden, Kellen D. Karsten, Stanislav L. Bragin, Anatol Kudo, Lili C. Gehman, Lauren Ruidera, Josephine Geschwind, Daniel H. Engel, Jerome PLoS One Research Article Neither the molecular basis of the pathologic tendency of neuronal circuits to generate spontaneous seizures (epileptogenicity) nor anti-epileptogenic mechanisms that maintain a seizure-free state are well understood. Here, we performed transcriptomic analysis in the intrahippocampal kainate model of temporal lobe epilepsy in rats using both Agilent and Codelink microarray platforms to characterize the epileptic processes. The experimental design allowed subtraction of the confounding effects of the lesion, identification of expression changes associated with epileptogenicity, and genes upregulated by seizures with potential homeostatic anti-epileptogenic effects. Using differential expression analysis, we identified several hundred expression changes in chronic epilepsy, including candidate genes associated with epileptogenicity such as Bdnf and Kcnj13. To analyze these data from a systems perspective, we applied weighted gene co-expression network analysis (WGCNA) to identify groups of co-expressed genes (modules) and their central (hub) genes. One such module contained genes upregulated in the epileptogenic region, including multiple epileptogenicity candidate genes, and was found to be involved the protection of glial cells against oxidative stress, implicating glial oxidative stress in epileptogenicity. Another distinct module corresponded to the effects of chronic seizures and represented changes in neuronal synaptic vesicle trafficking. We found that the network structure and connectivity of one hub gene, Sv2a, showed significant changes between normal and epileptogenic tissue, becoming more highly connected in epileptic brain. Since Sv2a is a target of the antiepileptic levetiracetam, this module may be important in controlling seizure activity. Bioinformatic analysis of this module also revealed a potential mechanism for the observed transcriptional changes via generation of longer alternatively polyadenlyated transcripts through the upregulation of the RNA binding protein HuD. In summary, combining conventional statistical methods and network analysis allowed us to interpret the differentially regulated genes from a systems perspective, yielding new insight into several biological pathways underlying homeostatic anti-epileptogenic effects and epileptogenicity. Public Library of Science 2011-06-14 /pmc/articles/PMC3114768/ /pubmed/21695113 http://dx.doi.org/10.1371/journal.pone.0020763 Text en Winden et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Winden, Kellen D.
Karsten, Stanislav L.
Bragin, Anatol
Kudo, Lili C.
Gehman, Lauren
Ruidera, Josephine
Geschwind, Daniel H.
Engel, Jerome
A Systems Level, Functional Genomics Analysis of Chronic Epilepsy
title A Systems Level, Functional Genomics Analysis of Chronic Epilepsy
title_full A Systems Level, Functional Genomics Analysis of Chronic Epilepsy
title_fullStr A Systems Level, Functional Genomics Analysis of Chronic Epilepsy
title_full_unstemmed A Systems Level, Functional Genomics Analysis of Chronic Epilepsy
title_short A Systems Level, Functional Genomics Analysis of Chronic Epilepsy
title_sort systems level, functional genomics analysis of chronic epilepsy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3114768/
https://www.ncbi.nlm.nih.gov/pubmed/21695113
http://dx.doi.org/10.1371/journal.pone.0020763
work_keys_str_mv AT windenkellend asystemslevelfunctionalgenomicsanalysisofchronicepilepsy
AT karstenstanislavl asystemslevelfunctionalgenomicsanalysisofchronicepilepsy
AT braginanatol asystemslevelfunctionalgenomicsanalysisofchronicepilepsy
AT kudolilic asystemslevelfunctionalgenomicsanalysisofchronicepilepsy
AT gehmanlauren asystemslevelfunctionalgenomicsanalysisofchronicepilepsy
AT ruiderajosephine asystemslevelfunctionalgenomicsanalysisofchronicepilepsy
AT geschwinddanielh asystemslevelfunctionalgenomicsanalysisofchronicepilepsy
AT engeljerome asystemslevelfunctionalgenomicsanalysisofchronicepilepsy
AT windenkellend systemslevelfunctionalgenomicsanalysisofchronicepilepsy
AT karstenstanislavl systemslevelfunctionalgenomicsanalysisofchronicepilepsy
AT braginanatol systemslevelfunctionalgenomicsanalysisofchronicepilepsy
AT kudolilic systemslevelfunctionalgenomicsanalysisofchronicepilepsy
AT gehmanlauren systemslevelfunctionalgenomicsanalysisofchronicepilepsy
AT ruiderajosephine systemslevelfunctionalgenomicsanalysisofchronicepilepsy
AT geschwinddanielh systemslevelfunctionalgenomicsanalysisofchronicepilepsy
AT engeljerome systemslevelfunctionalgenomicsanalysisofchronicepilepsy